A group of researchers in Edo state say they have produced a herbal drug “specifically for the treatment of COVID-19”.
Pax Herbal Clinic and Research Laboratories said the drug, named CVD PLUS, contains herbs and other constituents that “can stimulate antibody production against coronavirus related diseases”.
“Paxherbals has developed a novel drug, called CVD PLUS, specifically for the treatment of COVID-19. Pax CVD PLUS contains herbs and active phytoconstituents with documented scientific formulations of Paxherbals over the past 25 years for the treatment of hepatitis C, tuberculosis, HIV/AIDS, bronchitis, pneumonia and malaria,” the laboratory said in a statement on Wednesday.
“Some bio-active constituents of CVD PLUS are potential antiviral agents and immunomodulatory agents that can stimulate antibody production against coronavirus related diseases.”We May Ask Madagascar To Send Us A Plane Load Of Herbs To Treat COVID-19, Says SGF
The laboratory, which claims it was established in 1996 “for the promotion, development and proper utilisation of African medicine,” said representatives of some federal government agencies including the National Agency for Food and Drug Administration and Control (NAFDAC) were involved in the process of the production.